Response Genetics Extends Pact with Taiho | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics today said that it has extended an agreement with Taiho Pharmaceutical to provide testing and analysis services.

The Los Angeles-based molecular diagnostic firm will provide its services for molecular markers used in research diagnostics and the therapeutic treatment of cancer, it said, adding it will receive at least $950,000 for services provided during the extended period of Jan. 1 to Dec. 31, 2013.

Response and Tokyo-based Taiho first collaborated in 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.